首页 | 本学科首页   官方微博 | 高级检索  
     


Evaluation of Verbascum species and harpagoside in models of acute and chronic inflammation
Authors:Petya Dimitrova  Milen I. Georgiev  Mahmud T. H. Khan  Nina Ivanovska
Affiliation:1. Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria
2. Natural Products Laboratory, Institute of Biology, Leiden University, 2300 RA, Leiden, The Netherlands
3. Laboratory of Applied Biotechnologies, Institute of Microbiology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria
4. Center for Pharmaceutical Biotechnology, College of Pharmacy, University of Illinois at Chicago, IL, 60607-7173, Chicago, USA
Abstract:Verbascum species are widely used in folk medicine because of their broad range of biological activities. Harpagoside, an iridoid glycoside isolated from some Verbascum plants is known for its anti-inflammatory properties. In the present study, the effect of five extracts of Verbascum species and harpagosides were evaluated in mouse models of acute and chronic inflammation. The results demonstrate that Verbascum phoeniceum extract strongly inhibits COX-1 (60.2% inhibition vs PMA-stimulated cells) and COX-2 (44.8% inhibition) expression stimulated peritoneal macrophages resulting in reduced paw swelling in carrageenan-induced oedema (55.5% inhibition vs PBS-treated mice). Harpagoside ameliorated the development of zymosaninduced arthritis and reduced pathological changes in joints as shown by the decreased histological score for cell infiltration in synovial cavity (3.5±0.2 in vs 2.0±0.16), cartilage loss (2.5±0.3 vs 1.8±0.5) and bone resorption (2.4±0.2 vs 1.8±0.4). Molecular docking simulations of harpagoside suggest that it may function with increased specific affinity towards COX-1 than COX-2. The potential of harpagoside to be applied as an effective agent for treating joint-related disorders is discussed.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号